디지털 치료제 및 처방전 대상 헬스케어 앱 시장 예측(-2034년) - 치료 영역, 제공 형태, 비즈니스 모델, 기술 유형, 최종사용자 및 지역별 분석

According to Stratistics MRC, the Global Digital Therapeutics & Prescription Health Apps Market is accounted for $10.9 billion in 2026 and is expected to reach $80.0 billion by 2034 growing at a CAGR of 28.3% during the forecast period. Digital Therapeutics & Prescription Health Apps comprise an expanding healthcare field that employs clinically evaluated software to help prevent, manage, and treat various health conditions. These platforms deliver tailored therapeutic interventions through mobile phones, tablets, and connected technologies, allowing patients to receive care outside traditional healthcare environments. Prescription applications can address mental and behavioral health, chronic conditions, treatment adherence, and rehabilitation needs. Rising digital healthcare adoption, widespread smartphone use, demand for accessible treatment, and increasing provider acceptance are accelerating development. Advanced capabilities such as artificial intelligence, remote monitoring, and electronic health record integration are enhancing personalization and patient outcomes.

According to the World Health Organization (WHO), 78% of Member States in the WHO European Region (40 of 51) explicitly included telehealth in their national digital-health strategies in the 2022 survey, indicating increasing institutional adoption of digital healthcare services.

Market Dynamics:

Driver:

Growing adoption of digital healthcare

The rising acceptance of digital healthcare solutions is significantly supporting the Digital Therapeutics & Prescription Health Apps Market. Consumers and healthcare professionals are increasingly turning toward digital platforms because they provide flexible, convenient, and individualized methods for managing different medical conditions. Mobile devices and connected technologies enable patients to receive therapeutic support remotely, limiting the need for repeated physical appointments. This growing acceptance is encouraging innovation in prescription health applications designed for behavioral conditions, chronic disease management, rehabilitation, and various other healthcare requirements.

Restraint:

Data privacy and security concerns

Privacy and cybersecurity challenges can limit the expansion of the Digital Therapeutics & Prescription Health Apps Market. Digital therapeutic platforms frequently handle sensitive patient information, such as medical histories, treatment outcomes, behavioral data, and identifying details. Potential breaches, unauthorized access, cyber threats, and weak information-management practices can undermine user confidence. Patients may hesitate to adopt these solutions when their information is transferred between applications or healthcare systems. Maintaining these protections can increase technical requirements, regulatory responsibilities, and operating expenses for companies developing digital therapeutic applications.

Opportunity:

Integration with remote patient monitoring

The growing integration of remote patient monitoring creates promising opportunities for the Digital Therapeutics & Prescription Health Apps Market. Digital therapeutic platforms connected with wearable devices and monitoring technologies can continuously capture relevant patient information, allowing clinicians to better evaluate treatment progress. Sensors and smartphones can track health indicators, behaviors, and adherence outside traditional appointments. With healthcare providers increasingly adopting remote care models, companies can create connected therapeutic solutions that enhance chronic disease management while broadening the application and value of prescription-based digital health technologies.

Threat:

Rapid technological evolution and obsolescence

Fast-paced technological advancement can create challenges for the Digital Therapeutics & Prescription Health Apps Market as digital platforms, smart devices, and artificial intelligence technologies continue evolving. Providers must regularly enhance their applications to maintain functionality, compatibility, and clinical relevance. Rapid obsolescence can reduce patient engagement while increasing software development and maintenance costs. Incompatibility with devices, operating systems, or healthcare infrastructure may also interrupt services. Smaller companies can be particularly vulnerable because they may lack resources for continuous innovation. Frequent technology changes may consequently create uncertainty around platform reliability, long-term usability, and sustained investment in digital therapeutic solutions.

Covid-19 Impact:

The COVID-19 outbreak acted as a major catalyst for the Digital Therapeutics & Prescription Health Apps Market as healthcare systems rapidly shifted toward remote care. Patients and providers increasingly relied on digital applications for therapeutic interventions, monitoring, behavioral health services, and chronic condition management. Temporary regulatory measures further supported access to selected digital therapeutic products. The substantial growth in telehealth usage demonstrated the value of virtual healthcare delivery and improved user acceptance. Consequently, the pandemic expanded awareness of digital treatment options and encouraged greater adoption, investment, and long-term development of prescription health applications.

The diabetes management segment is expected to be the largest during the forecast period

The diabetes management segment is expected to account for the largest market share during the forecast period. Its dominance is driven by the effectiveness of digital technologies in supporting ongoing diabetes management through glucose tracking, treatment adherence, healthy lifestyle guidance, nutritional recommendations, and individualized interventions. Digital therapeutic platforms also enable continuous patient engagement and remote monitoring, helping healthcare professionals evaluate treatment progress. The persistent requirement for diabetes care, combined with increasing adoption of convenient technology-based healthcare solutions, continues to reinforce the importance of this segment within the market.

The AI-driven predictive & monitoring tools segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-driven predictive & monitoring tools segment is predicted to witness the highest growth rate. These technologies integrate artificial intelligence, predictive analytics, and continuous health monitoring to detect potential risks, forecast treatment requirements, and facilitate earlier interventions. By processing clinical and patient-generated information, they can deliver individualized recommendations and strengthen long-term disease management. Their capacity to support proactive care, personalized treatment, and remote monitoring is increasing their relevance. Continued integration of advanced AI capabilities into digital healthcare platforms is expected to encourage wider adoption across multiple therapeutic areas.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by sophisticated healthcare systems, strong digital infrastructure, and increasing acceptance of technology-based treatment solutions. Supportive regulatory conditions, developing reimbursement mechanisms, and significant investments are encouraging market expansion across the region. Healthcare professionals and patients are becoming increasingly familiar with digital therapeutic technologies, further supporting adoption. Moreover, the presence of established healthcare and technology companies, rising use of telehealth services, and growing requirements for effective chronic disease management are reinforcing North America's dominant position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid digital transformation across healthcare systems. Rising smartphone usage, improved connectivity, and expanding digital infrastructure are making technology-based therapeutic solutions increasingly accessible. The growing prevalence of chronic conditions and the need for cost-effective and convenient healthcare are supporting market expansion. In addition, government-led digital health programs, increasing telehealth adoption, and rising investment in healthcare technologies are accelerating development. India, China, Japan, and South Korea are among the key markets contributing to the region's strong growth prospects.

Key players in the market

Some of the key players in Digital Therapeutics & Prescription Health Apps Market include Omada Health Inc., Click Therapeutics, Akili Interactive, Big Health, Teladoc Health, Inc., Welldoc, Inc., ResMed Inc., DeepWell DTx, Sword Health, Otsuka Pharmaceutical, CureApp, Inc., Virta Health, Better Therapeutics, DarioHealth, Orexo AB, Sidekick Health, GAIA AG and Noom, Inc.

Key Developments:

In January 2026, Teladoc Health announced the launch of new enhancements to its 24/7 Care service. The new capabilities build on the company's flagship virtual urgent care service which provides access to licensed care providers who assess and treat non-emergency medical needs, 24 hours a day, seven days a week.

In May 2025, Resmed announced that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF). VirtuOx provides diagnostic services for sleep, respiratory and cardiac conditions. San Diego-based Resmed, a leader in sleep apnea therapy and digital offerings, says the acquisition reflects its commitment to making care more accessible, more coordinated and more patient-friendly.

Therapeutic Areas Covered:

• Diabetes Management
• Cardiovascular Health
• Neurological Disorders
• Mental Health & Behavioural Disorders
• Respiratory Conditions
• Oncology Support
• Musculoskeletal & Pain Management
• Sleep Disorders

Delivery Modes Covered:

• Smartphone Applications
• Wearable-Integrated Solutions
• Web-Based Platforms
• Virtual Reality & Augmented Reality Therapeutics

Business Models Covered:

• Direct-to-Consumer (D2C)
• Business-to-Business (B2B) with Providers
• Business-to-Business (B2B) with Payers & Insurers
• Hybrid Subscription Models

Technology Types Covered:

• Standalone Digital Therapeutics (DTx) Platforms
• Prescription Health Apps
• AI-Driven Predictive & Monitoring Tools
• Gamified Therapeutic Platforms

End Users Covered:

• Patients
• Healthcare Providers
• Payers & Insurers
• Employers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Digital Therapeutics & Prescription Health Apps Market, By Therapeutic Area

• 5.1 Diabetes Management
• 5.2 Cardiovascular Health
• 5.3 Neurological Disorders
• 5.4 Mental Health & Behavioural Disorders
• 5.5 Respiratory Conditions
• 5.6 Oncology Support
• 5.7 Musculoskeletal & Pain Management
• 5.8 Sleep Disorders

6 Global Digital Therapeutics & Prescription Health Apps Market, By Delivery Mode

• 6.1 Smartphone Applications
• 6.2 Wearable-Integrated Solutions
• 6.3 Web-Based Platforms
• 6.4 Virtual Reality & Augmented Reality Therapeutics

7 Global Digital Therapeutics & Prescription Health Apps Market, By Business Model

• 7.1 Direct-to-Consumer (D2C)
• 7.2 Business-to-Business (B2B) with Providers
• 7.3 Business-to-Business (B2B) with Payers & Insurers
• 7.4 Hybrid Subscription Models

8 Global Digital Therapeutics & Prescription Health Apps Market, By Technology Type

• 8.1 Standalone Digital Therapeutics (DTx) Platforms
• 8.2 Prescription Health Apps
• 8.3 AI-Driven Predictive & Monitoring Tools
• 8.4 Gamified Therapeutic Platforms

9 Global Digital Therapeutics & Prescription Health Apps Market, By End User

• 9.1 Patients
• 9.2 Healthcare Providers
• 9.3 Payers & Insurers
• 9.4 Employers

10 Global Digital Therapeutics & Prescription Health Apps Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Omada Health Inc.
• 13.2 Click Therapeutics
• 13.3 Akili Interactive
• 13.4 Big Health
• 13.5 Teladoc Health, Inc.
• 13.6 Welldoc, Inc.
• 13.7 ResMed Inc.
• 13.8 DeepWell DTx
• 13.9 Sword Health
• 13.10 Otsuka Pharmaceutical
• 13.11 CureApp, Inc.
• 13.12 Virta Health
• 13.13 Better Therapeutics
• 13.14 DarioHealth
• 13.15 Orexo AB
• 13.16 Sidekick Health
• 13.17 GAIA AG
• 13.18 Noom, Inc.